Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

150 PROCARE – phase 2 KCE reports 81TUMOUR REGRESSION GRADE MENTIONED IN PATHOLOGYREPORT (AFTER NEOADJUVANT TREATMENT)Measurement in prospective PROCARE database (Figure 60)In the hospital data section of the PROCARE data entry form, the variable ‘AD_V111’ ischecked if the patient underwent rectal surgery. Patients receiving neoadjuvanttreatment are registered using variables ‘RD_V101’ (radiotherapy), ‘CH_V101’(chemoradiotherapy) or ‘CH_V103’ (chemotherapy).Tumour regression grade is registered through variables ‘PT_V149’ and ‘PT_V150’ inthe pathology section.Measurement in coupled administrative databaseNo administrative code exists for the tumour regression grade, which are also data thatcan only be retrieved from the medical file.Figure 60. Algorithm for QI 1276 (prospective database).All patientsN=1071SurgeryN=1058NeoadjuvanttreatmentN=596Pathology reportN=575Surgery?Pathologyreport?Regression gradeknownN=539,22%Neoadjuvanttreatment?No pathology reportN=21Regressiongrade?No surgeryN=13No neoadjuvanttreatmentN=333Regression gradeMISSINGN=522Neoadjuvanttreatment:MISSINGN=129
KCE Reports 81 PROCARE – phase 2 151APPENDIX 3: CODES USED FROM THEPROSPECTIVE DATASETCode Description Value(s)AD_V111 Surgery 0 = no/missing, 1 = yesAD_V113 Radiotherapy (1) 0 = no/missing, 1 = yesAD_V114 Chemotherapy (1) 0 = no/missing, 1 = yesAD_V117 Radiotherapy (2) 0 = no/missing, 1 = yesAD_V118 Chemotherapy (2) 0 = no/missing, 1 = yesAD_V121 Radiotherapy (3) 0 = no/missing, 1 = yesAD_V122 Chemotherapy (3) 0 = no/missing, 1 = yesSPR_V110 Lower limit primary tumour Numericbased on rigid rectoscopySPR_V112 Lower limit primary tumour Numericbased on coloscopySPR_V122 cT based on CT 1 = Tx, 2 = T0, 3 = Tis, 4 = T1, 5 = T2, 6 = T3, 7 =T4, 8 = TisM, 9 = T1M, 10 = T2M, 11 = T3M, 12 =T4MSPR_V123 cT based on KST Same as SPR_V122SPR_V124 cT based on EUS Same as SPR_V122SPR_V125 cT based on MRI Same as SPR_V122SPR_V126 cN based on CT 1 = N0, 2 = N1, 3 = N2, 4 = NxSPR_V127 cN based on KST Same as SPR_V126SPR_V128 cN based on EUS Same as SPR_V126SPR_V129 cN based on MRI Same as SPR_V126SPR_V130 cCRM lateral or circumferential Numericmargin estimated at MRI - CTSPR_V131 cCRM lateral or circumferential Numericmargin estimated at NMR - CTSPR_V141 cM based on CT 0 = no/missing, 1 = yesSPR_V143 cM based on RX 0 = no/missing, 1 = yesSPR_V147 Summary clinical TNMSPR_V148 CEA serum before treatment NumericSPR_V149 Total coloscopy 0 = no/missing, 1 = yesSPR_V154 No total coloscopy – reason = 0 = no/missing, 1 = yestumour stenosisSPR_V155 No total coloscopy – reason = 0 = no/missing, 1 = yesinsufficient preparationSPR_V156 No total coloscopy – reason = 0 = no/missing, 1 = yesintolerance of patientSPR_V157 No total coloscopy – reason = 0 = no/missing, 1 = yestechnical reasonsSPR_V158 No total coloscopy – reason = 0 = no/missing, 1 = yesotherSPR_V161 Coloscopy – biopsy of the Datetumour: dateSPR_V171 Double contrast barium enema 1 = complete, 2 = incompletecomplete/incompleteSG_V105 Planned type resection 1 = local excision, 2 = sphincter saving radicalresection, 3 = APR, 4 = Hartmann, 5 = no resection(e.g. palliative stoma)SG_V106 Date of surgery DateSG_V109 Mode of surgery 1 = elective, 2 = scheduled, 3 = urgent, 4 =emergencySG_V110 Lower limit primary tumourabove margo aniNumeric
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110: KCE Reports 81 PROCARE - phase 2 99
Page 159: KCE Reports 81 PROCARE - phase 2 14
Page 169: KCE Reports 81 PROCARE - phase 2 15
Page 172 and 173: Dépôt légal : D/2008/10.273/39
Page 174 and 175: 35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

Create successful ePaper yourself

Delete template?

Save as template?